Loading…
Based on limited metadata, this FDA Warning Letter issued on August 28, 2020, addresses Dr. Sam Robbins, Inc. (operating as HFL Solutions, LLC), a company involved in drug products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the issuing office is not specified in the metadata provided.